Results 81 to 90 of about 3,561,997 (213)

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) [PDF]

open access: yes, 2009
BACKGROUND: In this study we aimed to evaluate the role of a SNP in intron I of the ERCC4 gene (rs744154), previously reported to be associated with a reduced risk of breast cancer in the general population, as a breast cancer risk modifier in BRCA1 and ...
Rodriguez, GC   +809 more
core   +1 more source

T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume

open access: yesHemaSphere, 2022
Ryan C. Lynch   +26 more
doaj   +1 more source

Identification of targetable FGFR gene fusions in diverse cancers [PDF]

open access: yes, 2013
[[abstract]]Through a prospective clinical sequencing program for advanced cancers, four index cases were identified which harbor gene rearrangements of FGFR2, including patients with cholangiocarcinoma, breast cancer, and prostate cancer.
Wu, YM;Su, F;Kalyana-Sundaram, S;Khazanov, N;Ateeq, B;Cao, X;Lonigro, RJ;Vats, P;Wang, R;Lin, SF;Cheng, AJ;Kunju, LP;Siddiqui, J;Tomlins, SA;Wyngaard, P;Sadis, S;Roychowdhury, S;Hussain, MH;Feng, FY;Zalupski, MM;Talpaz, M;Pienta, KJ;Rhodes, DR;Robinson, DR;Chinnaiyan, AM
core   +1 more source

PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES

open access: yesHemaSphere, 2023
Adam Olszewski   +9 more
doaj   +1 more source

Transient increase in skeletal-related events after discontinuation of high-dose denosumab in cancer patients

open access: yesJournal of Bone Oncology
Background: Denosumab is widely used to prevent skeletal-related events (SREs) in patients with bone metastases. However, rebound bone resorption after discontinuation is recognized.
Nokitaka Setsu   +5 more
doaj   +1 more source

Two Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma

open access: yesCase Reports in Otolaryngology, 2017
Ectopic hamartomatous thymoma (EHT) is an extremely rare benign tumor. EHTs are difficult to differentiate from sarcomas, especially synovial sarcomas. We encountered two cases of EHT that were referred from other hospitals because sarcoma was suspected.
Takahito Kondo   +8 more
doaj   +1 more source

Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study

open access: yesInfectious Agents and Cancer, 2016
Background The incidence of hepatocellular carcinoma (HCC) and its association with hepatitis C (HCV) and hepatitis B virus (HBV) infections, FIB-4 index and liver enzymes was assessed in an area of the province of Naples covered by a population-based ...
Mario Fusco   +12 more
doaj   +1 more source

Gene amplifications associated with the development of hormone- resistant prostate cancer [PDF]

open access: yes, 2003
Purpose: Hormone resistance remains a significant clinical problem in prostate cancer with few therapeutic options. Research into mechanisms of hormone resistance is essential.
Krishnan, S.   +3 more
core  

Cervical cancer screening programmes and policies in 18 European countries. [PDF]

open access: yes, 2004
A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries ...
Weiderpass, E   +20 more
core   +1 more source

Galectin 3 for the diagnosis of bladder cancer

open access: yesArab Journal of Urology, 2014
To evaluate serum levels of galectin-3 (G-3) in patients with bladder cancer and a control group, as a potential diagnostic and prognostic serum tumour marker.Between November 2012 and January 2013, 55 patients (median age 58 years) were enrolled into three groups, i.e., a control, those with transitional cell carcinoma (TCC) or those with squamous ...
El Gendy, Hoda   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy